Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 4.65
(1.09%)
CNY 4.65
(1.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 15.33 Million CNY | 127.26% |
| 2022 | -56.27 Million CNY | -351.0% |
| 2021 | 22.41 Million CNY | 143.97% |
| 2020 | -50.98 Million CNY | -908.09% |
| 2019 | 6.3 Million CNY | -84.41% |
| 2018 | 40.47 Million CNY | -44.61% |
| 2017 | 73.06 Million CNY | 4.91% |
| 2016 | 69.64 Million CNY | -55.7% |
| 2015 | 157.21 Million CNY | 22.56% |
| 2014 | 128.28 Million CNY | 16.54% |
| 2013 | 110.07 Million CNY | 11.99% |
| 2012 | 98.28 Million CNY | 36.79% |
| 2011 | 71.85 Million CNY | 32.08% |
| 2010 | 54.39 Million CNY | 31.35% |
| 2009 | 41.41 Million CNY | 58.3% |
| 2008 | 26.16 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 3.31 Million CNY | 222.41% |
| 2024 Q3 | 465.47 Thousand CNY | -85.94% |
| 2024 Q1 | -2.7 Million CNY | 67.91% |
| 2023 Q1 | 8.29 Million CNY | 109.14% |
| 2023 Q4 | -8.42 Million CNY | -215.81% |
| 2023 FY | 15.33 Million CNY | 127.26% |
| 2023 Q3 | 7.27 Million CNY | -11.15% |
| 2023 Q2 | 8.19 Million CNY | -1.26% |
| 2022 FY | -56.27 Million CNY | -351.0% |
| 2022 Q3 | 10.53 Million CNY | -10.93% |
| 2022 Q4 | -90.74 Million CNY | -961.42% |
| 2022 Q1 | 12.1 Million CNY | 282.41% |
| 2022 Q2 | 11.82 Million CNY | -2.33% |
| 2021 Q4 | -6.63 Million CNY | -142.85% |
| 2021 Q1 | 6.26 Million CNY | 111.2% |
| 2021 Q2 | 7.29 Million CNY | 16.34% |
| 2021 Q3 | 15.49 Million CNY | 112.4% |
| 2021 FY | 22.41 Million CNY | 143.97% |
| 2020 FY | -50.98 Million CNY | -908.09% |
| 2020 Q4 | -55.98 Million CNY | -610.99% |
| 2020 Q3 | 10.95 Million CNY | 15.14% |
| 2020 Q2 | 9.51 Million CNY | 161.5% |
| 2020 Q1 | -15.47 Million CNY | -247.2% |
| 2019 FY | 6.3 Million CNY | -84.41% |
| 2019 Q4 | -4.45 Million CNY | -271.66% |
| 2019 Q3 | 2.59 Million CNY | 16.32% |
| 2019 Q2 | 2.23 Million CNY | -62.41% |
| 2019 Q1 | 5.93 Million CNY | 128.72% |
| 2018 Q2 | 19.99 Million CNY | 8.94% |
| 2018 Q1 | 18.35 Million CNY | 9.37% |
| 2018 Q3 | 22.79 Million CNY | 14.02% |
| 2018 FY | 40.47 Million CNY | -44.61% |
| 2018 Q4 | -20.67 Million CNY | -190.69% |
| 2017 Q2 | 23.85 Million CNY | 43.71% |
| 2017 Q4 | 16.78 Million CNY | 6.04% |
| 2017 FY | 73.06 Million CNY | 4.91% |
| 2017 Q1 | 16.6 Million CNY | -25.48% |
| 2017 Q3 | 15.82 Million CNY | -33.67% |
| 2016 Q2 | 17.38 Million CNY | -3.62% |
| 2016 Q3 | 11.94 Million CNY | -31.32% |
| 2016 Q4 | 22.27 Million CNY | 86.53% |
| 2016 FY | 69.64 Million CNY | -55.7% |
| 2016 Q1 | 18.04 Million CNY | -76.93% |
| 2015 Q2 | 33.97 Million CNY | 128.06% |
| 2015 Q4 | 78.2 Million CNY | 159.48% |
| 2015 FY | 157.21 Million CNY | 22.56% |
| 2015 Q3 | 30.13 Million CNY | -11.3% |
| 2015 Q1 | 14.89 Million CNY | -76.15% |
| 2014 FY | 128.28 Million CNY | 16.54% |
| 2014 Q4 | 62.46 Million CNY | 187.08% |
| 2014 Q3 | 21.76 Million CNY | -31.42% |
| 2014 Q2 | 31.72 Million CNY | 157.41% |
| 2014 Q1 | 12.32 Million CNY | -14.04% |
| 2013 Q3 | 32.34 Million CNY | -18.81% |
| 2013 FY | 110.07 Million CNY | 11.99% |
| 2013 Q2 | 39.84 Million CNY | 69.26% |
| 2013 Q4 | 14.33 Million CNY | -55.67% |
| 2013 Q1 | 23.54 Million CNY | -1.39% |
| 2012 Q1 | 17.82 Million CNY | -8.76% |
| 2012 Q2 | 31.37 Million CNY | 76.05% |
| 2012 FY | 98.28 Million CNY | 36.79% |
| 2012 Q3 | 25.21 Million CNY | -19.63% |
| 2012 Q4 | 23.87 Million CNY | -5.34% |
| 2011 Q1 | 12.99 Million CNY | 0.0% |
| 2011 Q3 | 18.89 Million CNY | -7.5% |
| 2011 Q2 | 20.42 Million CNY | 57.12% |
| 2011 FY | 71.85 Million CNY | 32.08% |
| 2011 Q4 | 19.53 Million CNY | 3.39% |
| 2010 FY | 54.39 Million CNY | 31.35% |
| 2009 FY | 41.41 Million CNY | 58.3% |
| 2008 FY | 26.16 Million CNY | 0.0% |